Lu Li

Stock Analyst at UBS

(2.17)
# 1104
Out of 5,240 analysts
3
Total ratings
100.00%
Success rate
18.26%
Average return
2 Stocks
Name Action Price Target Current % Upside Ratings Updated
Myriad Genetics
Initiates Coverage On: Neutral
18
13.46 33.73% 1 Dec 10, 2024
Veracyte
Maintains: Strong Buy
43 46
42.56 8.08% 2 Nov 7, 2024